Cinven is tapping banks to help finance its acquisition of specialty pharmaceutical company Theramex with debt financing of around €1.5 billion ($1.7 billion).
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.